Caribou Biosciences, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ADPT
|
Adaptive Biotechnologies Corporation | $4.33 | $532.00 M | -2.42 | 709 | $170.28 M |
 BEAM
|
Beam Therapeutics Inc. | $23.78 | $1.91 B | -14.51 | 472 | $377.71 M |
 CRSP
|
CRISPR Therapeutics AG | $46.88 | $4.91 B | -21.43 | 407 | $371.21 M |
 EDIT
|
Editas Medicine, Inc. | $2.42 | $435.86 M | -2.56 | 265 | $78.12 M |
 FATE
|
Fate Therapeutics, Inc. | $2.22 | $418.90 M | -1.92 | 181 | $63.53 M |
 NTLA
|
Intellia Therapeutics, Inc. | $14.20 | $2.19 B | -4.23 | 526 | $36.28 M |
 PRME
|
Prime Medicine, Inc. | $3.03 | $788.60 M | -3.01 | 234 | $0 |
 SANA
|
Sana Biotechnology, Inc. | $2.61 | $1.55 B | -4.59 | 328 | $0 |
 VERV
|
Verve Therapeutics, Inc. | $4.69 | $409.24 M | -1.82 | 255 | $11.76 M |